DL
IONS icon

Delta Lloyd’s Ionis Pharmaceuticals IONS Stock Holding History

Delta Lloyd’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-8,539
Closed -$346K – 671
2016
Q1 		$346K Hold
8,539
– – 0.01% 626
2015
Q4 		$529K Hold
8,539
– – 0.02% 544
2015
Q3 		$345K Hold
8,539
– – 0.01% 648
2015
Q2 		$491K Buy
8,539
+3,411
+67% +$217K 0.02% 579
2015
Q1 		$326K Buy
+5,128
New +$348K 0.01% 577

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return

Delta Lloyd's IONS Position: Q2 2016 in Review

Delta Lloyd sold out of Ionis Pharmaceuticals (IONS) in Q2 2016, closing a stake of 8,539 shares — an estimated $346K sold.

Delta Lloyd first reported a position in IONS in Q1 2015 and held it in 5 quarters. The position peaked at $529K in Q4 2015. 282 funds tracked by Wall St. Rank hold IONS as of Q2 2016.

  • Delta Lloyd reported no remaining Ionis Pharmaceuticals position as of Q2 2016 after selling out during the quarter.
  • Delta Lloyd sold 8,539 Ionis Pharmaceuticals shares in Q2 2016, an estimated $346K.
  • Delta Lloyd first reported a position in Ionis Pharmaceuticals in Q1 2015 and held it in 5 quarters.
  • Delta Lloyd's Ionis Pharmaceuticals position peaked at $529K in Q4 2015.
  • 282 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q2 2016.

Based on Delta Lloyd's 13F filing for Q2 2016, filed 4 Aug 2016.